Clinical Trial Update: Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating calorie restriction to prevent renal abnormalities in adults with abdominal obesity and type 2 diabetes; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED